Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Insulin degludec (Tresiba) for diabetes mellitus: Overview. Insulin degludec (trade name: Tresiba) has been approved in Germany since January 2013 for the treatment of type 1 and type 2 diabetes in adults. The drug is a long-acting insulin. It is used to regulate blood sugar levels for up to 24 hours.igher than normal amount of glucose (a type of sugar) in the blood. Hyperglycemia can be a sign of diabetes or other conditions. Also called high blood sugar. Hypoglycemia. Also called low blood glucose, a condition that occurs when one's blood glucose is lower than normal, usually below 70 mg/dL.